Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02032680 · ClinicalTrials.gov registry record · NA

Comparison of E-health vs. In-person Multi-Family Group (MFG)

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT02032680: Completed NA study, sponsored by VA Office of Research and Development.

NCT02032680 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02032680, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

As specified in the VA Uniform Services Handbook, Family Psycho-Education (FPE) treatment must be available to all Veterans with schizophrenia who could benefit, and their family members. This includes those receiving care at Community Based Outpatient Clinics (CBOCs), and at Psychosocial Rehabilitation and Recovery Centers (PRRCs), whether provided on site, by referral, or by telemental health. However, less than 5% of VA medical centers offer FPE. Clearly, a major challenge is to devise ways to deliver mental health treatments and services to Veterans who need them in ways that meet their needs and preferences. The proposed project will compare the use of a website to deliver FPE to that of in-person delivered FPE. The findings could have profound implications for the VA's ability to improve the reach, use, appeal, and effectiveness of FPE for Veterans with schizophrenia, by using an e-health model that facilitates family involvement.

Primary Outcome

At baseline, each participant developed a goal that she or he would work on to achieve as part of involvement in the study. Indicators of the 5 levels (0-4) of achievement, on the Goal Attainment Scale, were developed for each individual participant's goal, with each individual participant. The minimum was 0 (zero), the maximum was 4, and higher scores were better.

Interventions

  • OTHER Treatment as usual (TAU)
  • BEHAVIORAL Web-based multi-family psychoeducational treatment
  • BEHAVIORAL In-persons Multi-Family Group Psycho-Education treatment

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2015-08-19
Est. Completion 2018-09-30
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT02032680 record still lists

NCT02032680 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 3 interventions - of which Treatment as usual (TAU) is the first listed.

NCT02032680 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02032680 about?

NCT02032680 is a clinical study titled "Comparison of E-health vs. In-person Multi-Family Group (MFG)". As specified in the VA Uniform Services Handbook, Family Psycho-Education (FPE) treatment must be available to all Veterans with schizophrenia who could benefit, and their family members. This includes those receiving care at Community Based Outpatient Clinics (CBOCs), and at Psychosocial Rehabilita...

What is the current status of trial NCT02032680?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-08-19. Estimated completion is 2018-09-30.

What interventions are being tested in trial NCT02032680?

The interventions under investigation include: Treatment as usual (TAU) (OTHER), Web-based multi-family psychoeducational treatment (BEHAVIORAL), In-persons Multi-Family Group Psycho-Education treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT02032680?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02032680's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02032680, the US trial registry maintained by the National Library of Medicine. NCT02032680 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.